Patents by Inventor Alex Stegh

Alex Stegh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bcl2L12 polypeptide activators and inhibitors
    Patent number: 7595158
    Abstract: The invention provides methods and materials related to Bcl2L12 polypeptides and the biological activities of Bcl2L12 polypeptides. For example, the invention provides methods and materials related to identifying activators and inhibitors of Bcl2L12 polypeptide activities such as the ability to block apoptosis and promote cell growth and transformation. The invention also provides methods and materials for treating mammals having cancer.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: September 29, 2009
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Alex Stegh, Hyung Gee Kim, Ronald A. Depinho, Lynda Chin
  • Bcl2L12 polypeptide activators and inhibitors
    Publication number: 20060252053
    Abstract: The invention provides methods and materials related to Bcl2L12 polypeptides and the biological activities of Bcl2L12 polypeptides. For example, the invention provides methods and materials related to identifying activators and inhibitors of Bcl2L12 polypeptide activities such as the ability to block apoptosis and promote cell growth and transformation. The invention also provides methods and materials for treating mammals having cancer.
    Type: Application
    Filed: October 25, 2005
    Publication date: November 9, 2006
    Inventors: Alex Stegh, Hyung Kim, Ronald Depinho, Lynda Chin